Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets - Travert, Marion; Huang, Yenlin; de Leval, Laurence; Martin-Garcia, Nadine; Delfau-Larue, Marie-Helene; Berger, Françoise; Bosq, Jacques; Brière, Josette; Soulier, Jean; MacIntyre, Elizabeth; Marafioti, Teresa; de Reyniès, Aurélien; et al. (Blood, 2012)
Keywords: Adult; Aged; Base Sequence; Biological and medical sciences; Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; Cell Lineage - genetics; Chromosome Aberrations; Cluster Analysis; Crystallins - metabolism; Drug Resistance, Neoplasm - genetics; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm - genetics; Hematologic and hematopoietic diseases; Hematology; Human health and pathology; Humans; Intracellular Signaling Peptides and Proteins - antagonists & inhibitors; Intracellular Signaling Peptides and Proteins - metabolism; Isochromosomes - genetics; Life Sciences; Liver Neoplasms - drug therapy; Liver Neoplasms - genetics; Liver Neoplasms - pathology; Lymphoma, T-Cell - drug therapy; Lymphoma, T-Cell - genetics; Lymphoma, T-Cell - pathology; Male; Medical sciences; Membrane Proteins - metabolism; Middle Aged; Molecular Sequence Data; Molecular Targeted Therapy; Protein-Tyrosine Kinases - antagonists & inhibitors; Protein-Tyrosine Kinases - metabolism; Receptors, Antigen, T-Cell, alpha-beta - genetics; Receptors, Antigen, T-Cell, gamma-delta - genetics; Splenic Neoplasms - drug therapy; Splenic Neoplasms - genetics; Splenic Neoplasms - pathology; Syk Kinase; Young Adult; Treatment; Targeting; Hematology; T lymphoma; Digestive system; Targeted therapy; Liver